acetylcysteine has been researched along with Pulmonary Hypertension in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, W; Lin, C; Mi, L; Yu, W | 1 |
| Alfaro, TM; Cordeiro, CR; Freitas, S | 1 |
| Cottin, V | 1 |
| Ancochea, J; Bollo, E; Fernández-Fabrellas, E; Franquet, T; Molina-Molina, M; Montero, MA; Serrano-Mollar, A; Xaubet, A | 1 |
| Cai, D; Li, S; Li, X; Li, Y; Liao, X; Lin, Y; Liu, G; Pan, B; Wang, H; Zhu, L | 1 |
| Chaumais, MC; Cohen-Kaminsky, S; Dorfmüller, P; Guignabert, C; Humbert, M; Lecerf, F; Montani, D; Perros, F; Price, L; Ranchoux, B; Raymond, N; Simonneau, G; Tu, L | 1 |
| Ahmed, A; Gu, J; Gu, Y; Guo, D; Jiang, H; Zhang, Z | 1 |
| Lin, HC; Ma, L; Neu, J; Zhou, P | 1 |
| Hampl, V; Herget, J; Hnilicková, O; Lachmanová, V; Povýsilová, V | 1 |
| Huang, XL; Ling, YL; Ling, YQ; Zhang, JL; Zhu, TN | 1 |
| Marsden, PA | 1 |
| Ashino, Y; Fujimura, S; Hoshikawa, Y; Noda, M; Ono, S; Sakuma, T; Tabata, T; Tanita, T; Ueda, S | 1 |
| Chida, M; Fujimura, S; Hoshikawa, Y; Noda, M; Ono, S; Song, C; Suzuki, S; Tabata, T; Tanita, T; Voelkel, NF | 1 |
| Giordano, MP; Roncarolo, PL | 1 |
1 review(s) available for acetylcysteine and Pulmonary Hypertension
| Article | Year |
|---|---|
Potential Nutrients for Preventing or Treating Bronchopulmonary Dysplasia.
Topics: Acetylcysteine; Antioxidants; Arginine; Bronchopulmonary Dysplasia; Citrulline; Cysteine; Fatty Acids, Unsaturated; Glutamine; Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; Infant, Premature; Inositol; Selenium; Vitamin A; Vitamin B Complex | 2017 |
13 other study(ies) available for acetylcysteine and Pulmonary Hypertension
| Article | Year |
|---|---|
Mechanisms of N‑acetylcysteine in reducing monocrotaline‑induced pulmonary hypertension in rats: Inhibiting the expression of Nox1 in pulmonary vascular smooth muscle cells.
Topics: Acetylcysteine; Animals; Apoptosis; Cell Proliferation; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidase 1; Pulmonary Artery; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase; Vascular Remodeling | 2017 |
Clinical case: Differential diagnosis of idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Alveolitis, Extrinsic Allergic; Azathioprine; Diagnosis, Differential; Disease Management; Humans; Hypertension, Pulmonary; Idiopathic Pulmonary Fibrosis; Lung; Male; Middle Aged; Prednisolone; Pulmonary Emphysema; Radiography; Smoking | 2013 |
Clinical case: Combined pulmonary fibrosis and emphysema with pulmonary hypertension--clinical management.
Topics: Acetylcysteine; Azathioprine; Disease Management; Humans; Hypertension, Pulmonary; Lung; Male; Middle Aged; Oxygen Inhalation Therapy; Phenylpropionates; Prednisolone; Pulmonary Emphysema; Pulmonary Fibrosis; Pyridazines; Radiography; Smoking | 2013 |
Guidelines for the diagnosis and treatment of idiopathic pulmonary fibrosis. Sociedad Española de Neumología y Cirugía Torácica (SEPAR) Research Group on Diffuse Pulmonary Diseases.
Topics: Acetylcysteine; Biopsy; Bronchoalveolar Lavage Fluid; Cell- and Tissue-Based Therapy; Clinical Trials as Topic; Contraindications; Diagnostic Imaging; Disease Progression; Evidence-Based Medicine; Gastroesophageal Reflux; Genetic Therapy; Glucocorticoids; Humans; Hypertension, Pulmonary; Idiopathic Pulmonary Fibrosis; Immunologic Factors; Incidence; Indoles; Lung; Lung Transplantation; Oxygen Inhalation Therapy; Palliative Care; Prevalence; Prognosis; Pulmonary Emphysema; Pyridones; Risk Factors; Spain | 2013 |
H2S inhibition of chemical hypoxia-induced proliferation of HPASMCs is mediated by the upregulation of COX-2/PGI2.
Topics: Acetylcysteine; Cell Hypoxia; Cell Line; Cell Proliferation; Cobalt; Cyclooxygenase 2; Down-Regulation; Epoprostenol; Familial Primary Pulmonary Hypertension; Humans; Hydrogen Peroxide; Hydrogen Sulfide; Hypertension, Pulmonary; Myocytes, Smooth Muscle; Oxidative Stress; Pulmonary Artery; Reactive Oxygen Species; Sulfides | 2014 |
N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats.
Topics: Acetylcysteine; Animals; Cells, Cultured; Hypertension, Pulmonary; Male; Monocrotaline; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2014 |
Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to the development of pulmonary arterial hypertension.
Topics: Acetophenones; Acetylcysteine; Animals; Apoptosis; Calcium; Calcium Channels, L-Type; Cell Proliferation; Gene Expression Regulation; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Metalloporphyrins; Monocrotaline; Myocytes, Smooth Muscle; Organ Culture Techniques; Pentose Phosphate Pathway; Phosphorylation; Primary Cell Culture; Pulmonary Artery; Pyruvate Kinase; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Serine | 2016 |
N-acetylcysteine inhibits hypoxic pulmonary hypertension most effectively in the initial phase of chronic hypoxia.
Topics: Acetylcysteine; Animals; Antioxidants; Chronic Disease; Hypertension, Pulmonary; Hypoxia; Male; Rats; Rats, Wistar | 2005 |
Multiple factors contributing to lipopolysaccharide-induced reactivity changes in rabbit pulmonary artery.
Topics: Acetylcysteine; Animals; Carbon Monoxide; Hypertension, Pulmonary; Lipopolysaccharides; Male; Nitric Oxide; Pulmonary Artery; Rabbits; Shock, Septic | 2005 |
Low-molecular-weight S-nitrosothiols and blood vessel injury.
Topics: Acetylcysteine; Animals; Basic Helix-Loop-Helix Transcription Factors; Blood Vessels; Humans; Hypertension, Pulmonary; Molecular Weight; Nitric Oxide; S-Nitrosothiols; Vascular Diseases | 2007 |
[Contribution of oxidative stress to pulmonary hypertension induced by chronic hypoxia].
Topics: Acetylcysteine; Animals; Chronic Disease; Free Radical Scavengers; Hypertension, Pulmonary; Hypoxia; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley | 1995 |
Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia.
Topics: Acetylcysteine; Allopurinol; Animals; Antioxidants; Chronic Disease; Enzyme Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; Oxidative Stress; Oxygen; Phosphatidylcholines; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Tunica Media; Ventricular Function, Right; Xanthine Oxidase | 2001 |
[Modern trends in therapy of chronic pulmonary hypertensive cardiopathy].
Topics: Acetylcysteine; Acidosis, Respiratory; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Bacterial Agents; Bicarbonates; Bloodletting; Bronchodilator Agents; Central Nervous System Stimulants; Diuretics; Heart Failure; Humans; Hypertension, Pulmonary; Hypnotics and Sedatives; Oxygen Inhalation Therapy; Positive-Pressure Respiration; Potassium Chloride; Pulmonary Heart Disease; Sympatholytics | 1971 |